Proxy Statement (Form 8-K)

Item 5.08 Shareholder Director Nominations.

On September 3, 2026, the board of directors of Modular Medical, Inc. (the "Company") set October 23, 2026 as the date of the Company's fiscal 2027 Annual Meeting of Shareholders (the "2027 Annual Meeting"). The 2027 Annual Meeting will be a virtual meeting. Shareholders of record at the close of business on September 10, 2026 will be entitled to notice of and to vote at the 2027 Annual Meeting. Because the date of the 2027 Annual Meeting is more than 30 days before the anniversary date of the fiscal 2026 Annual Meeting of Shareholders, the Company is providing the due date for submission of any qualified shareholder proposal or qualified shareholder nominations.

Shareholders of the Company who wish to have a proposal considered for inclusion in the Company's proxy materials for the 2027 Annual Meeting pursuant to Rule 14a-8 under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), must ensure that such proposal is received by the Company's Secretary at its principal executive offices at the address set forth above on or prior to 5:00 p.m. (Eastern time) on September 13, 2026, which the Company has determined to be a reasonable time before it expects to begin to print and send its proxy materials. Any such proposal must also meet the requirements set forth in the rules and regulations of the Securities and Exchange Commission in order to be eligible for inclusion in the proxy materials for the 2027 Annual Meeting.

In addition, in accordance with the requirements contained in the Company's bylaws, shareholders of the Company who wish to bring business before the 2027 Annual Meeting outside of Rule 14a-8 of the Exchange Act or to nominate a person for election as a director must ensure that written notice of such proposal (including all information specified in the Company's bylaws) is received by the Company's Secretary at the Company's principal executive offices at the address set forth above no later than 5:00 p.m. (Eastern time) on September 13, 2026. Any such proposal must meet the requirements set forth in the Company's bylaws to be brought before the 2026 Annual Meeting.

In addition, to comply with the universal proxy rules, shareholders who intend to solicit proxies in support of director nominees other than the Company's nominees must provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act by 5:00 p.m. (Eastern time) on September 13, 2026, which is the tenth calendar day following the date of this Current Report on Form 8-K publicly announcing the date of the 2027 Annual Meeting.